Literature DB >> 2884443

When should at-risk patients with thalassaemia be boosted with hepatitis B vaccine?

N Matsaniotis, C Kattamis, S Laskari, M Tzeti, D Markosoglou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884443     DOI: 10.1016/s0140-6736(87)90576-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Intradermal hepatitis B vaccination in thalassaemia.

Authors:  S Leonardi; T Leggio; A Sciacca; F Di Gregorio; S Musumeci
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.